Ağaç ve Peyzaj A.Ş. üzerinden usulsüzlük yapıldığı ve ihaleye fesat karıştırıldığı iddiasıyla İBB'ye yeni operasyon ...
The estimated $8.1 million transaction represented about 1% of fund assets at the end of the quarter. Destiny Wealth now owns 16,430 shares valued at $2.4 million, which is about 0.3% of the firm's ...
A smart beta exchange traded fund, the iShares Biotechnology ETF (IBB) debuted on 02/05/2001, and offers broad exposure to the Health Care ETFs category of the market. The ETF industry has long been ...
The two biotech ETF products with around $8 billion in assets are IBB and XBI. At $133.36 on February 17, the iShares Biotechnology ETF (IBB) had $8.58 billion in assets under management. The S&P SPDR ...
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Biotechnology ETF (Symbol: IBB) where we have detected an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results